You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
利巴韋林概念股普跌 江蘇吳中(600200.SH)等4股跌停
格隆匯 02-11 14:21
格隆匯2月11日丨利巴韋林概念股普跌,其中,此前9個交易日內8漲停的江蘇吳中(600200.SH)今日跌停;8個交易日累漲77%的星湖科技(600866.SZ)今日為連續第二日跌停;此前連續8日漲停的魯抗醫藥(600789.SH)今日為連續第二日跌停;此前連續5日漲停的海王生物今日為連續第二日跌停。

此外,長江健康、誠意藥業、金花股份和延安必康等均出現明顯下跌。自第五版新冠病毒診療方案增加“利巴韋林”以來,截至今日,利巴韋林概念股的炒作或正式告一段落。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account